Online randomised factorial trial of electronic Screening and Brief Intervention for alcohol use in pregnancy: a study protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
03 08 2022
Historique:
entrez: 3 8 2022
pubmed: 4 8 2022
medline: 6 8 2022
Statut: epublish

Résumé

Approximately 1 in 7 pregnant women in the USA report past-month alcohol use. Strong evidence connects prenatal alcohol exposure with a range of adverse perinatal outcomes, including the spectrum of conditions known as fetal alcohol spectrum disorders. Screening and Brief Intervention (SBI) has been recommended for pregnant women but has proven difficult to implement. This study will test the efficacy of single-session technology-delivered SBI (electronic SBI) for alcohol use in pregnancy, while simultaneously evaluating the possible additional benefit of tailored text messages and/or booster sessions in a 3×2 factorial trial. This full factorial trial will use online advertising and clinic-based flyers to recruit pregnant women meeting criteria for unhealthy alcohol use, and randomly assign them to one of six conditions crossing three levels of brief intervention (none, single 120-minute session and single session plus two 5-minute boosters) with two levels of tailored text messaging (none vs twice weekly messages). The primary analysis will test for dose-response effects of the brief intervention on alcohol abstinence, defined as no self-report of alcohol use in the 90 days prior to 34 weeks' gestation, and negative results for ethyl glucuronide analysis of fingernail samples. Secondary analyses will examine main and interaction effects of tailored text messaging as well as intervention effects on birth outcomes. Ethical approval was provided by the Michigan State University Biomedical and Health Institutional Review Board (STUDY00005298). Results will be presented at conferences and community forums, in addition to being published in a peer-reviewed journal. Intervention content demonstrating sufficient efficacy and safety will be made publicly available. ClinicalTrials.gov Registry (NCT04332172).

Identifiants

pubmed: 35922101
pii: bmjopen-2022-062735
doi: 10.1136/bmjopen-2022-062735
pmc: PMC9352990
doi:

Banques de données

ClinicalTrials.gov
['NCT04332172']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e062735

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA026596
Pays : United States
Organisme : NIAAA NIH HHS
ID : T35 AA023760
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: JH has received research support from Pfizer. The authors declare that there are no other conflicts to report.

Références

Nicotine Tob Res. 2021 Aug 29;23(10):1810-1812
pubmed: 33876244
Obstet Gynecol. 2005 May;105(5 Pt 1):991-8
pubmed: 15863535
J Child Psychol Psychiatry. 2016 Feb;57(2):116-31
pubmed: 26251262
Subst Use Misuse. 2016 Jan 2;51(1):126-30
pubmed: 26771303
Psychol Bull. 2007 Jul;133(4):673-93
pubmed: 17592961
J Med Internet Res. 2014 Feb 05;16(2):e14
pubmed: 24500775
JAMA. 2018 Nov 13;320(18):1899-1909
pubmed: 30422199
Brain Behav. 2020 Jan;10(1):e01486
pubmed: 31793226
J Womens Health (Larchmt). 2011 Oct;20(10):1517-24
pubmed: 21823917
Alcohol Clin Exp Res. 2006 Jun;30(6):1051-9
pubmed: 16737465
JAMA. 2014 Aug 6;312(5):502-13
pubmed: 25096690
BMC Pregnancy Childbirth. 2014 Apr 03;14:127
pubmed: 24708684
Drug Alcohol Depend. 1996 Sep;42(1):49-54
pubmed: 8889403
Alcohol Clin Exp Res. 2015 Jul;39(7):1219-26
pubmed: 26010235
Subst Abus. 2015;36(1):13-20
pubmed: 24266770
Addiction. 2017 Jul;112(7):1238-1249
pubmed: 28239919
Pediatrics. 2016 Mar;137(3):e20152542
pubmed: 26908693
J Stud Alcohol Drugs. 2017 Nov;78(6):945-948
pubmed: 29087831
Epidemiology. 2009 Nov;20(6):884-91
pubmed: 19797967
Child Youth Serv Rev. 2018 Jan;84:198-205
pubmed: 29731531
Ann N Y Acad Sci. 1986;477:87-102
pubmed: 3468841
J Addict Med. 2010 Jun;4(2):114-21
pubmed: 21769028
Prev Med. 2015 Jul;76 Suppl:S33-8
pubmed: 25514547
Addiction. 2010 Apr;105(4):601-14
pubmed: 20403013
Am J Obstet Gynecol. 1989 Apr;160(4):863-8; discussion 868-70
pubmed: 2712118
Ann Intern Med. 2012 Nov 6;157(9):645-54
pubmed: 23007881
Addict Disord Their Treat. 2015 Dec;14(4):203-210
pubmed: 26755894
MMWR Morb Mortal Wkly Rep. 2022 Jan 07;71(1):10-13
pubmed: 34990444
Am J Prev Med. 2007 May;32(5 Suppl):S112-8
pubmed: 17466815
J Subst Abuse Treat. 2016 Jan;60:27-35
pubmed: 26297322
Trials. 2014 Apr 23;15:139
pubmed: 24755011
Acta Neuropsychiatr. 2015 Oct;27(5):251-69
pubmed: 25780875
Contemp Clin Trials. 2012 Sep;33(5):1074-9
pubmed: 22710564
Alcohol Res Health. 2011;34(1):86-91
pubmed: 23580045
Alcohol Clin Exp Res. 2014 Mar;38(3):853-9
pubmed: 24125097
Am J Obstet Gynecol. 2018 Mar;218(3):322.e1-322.e12
pubmed: 29247636
Toxicol Lett. 2017 Jun 5;275:49-56
pubmed: 28455000
Am Psychol. 2000 Jan;55(1):68-78
pubmed: 11392867
Am J Prev Med. 2020 Nov;59(5):768-769
pubmed: 33011009
Behav Res Methods. 2015 Dec;47(4):1237-1259
pubmed: 25410404
Addiction. 2021 May;116(5):1021-1033
pubmed: 33047865
Psychol Addict Behav. 2012 Sep;26(3):672-7
pubmed: 22486334
J Stud Alcohol. 2006 Mar;67(2):245-51
pubmed: 16562406
Metab Brain Dis. 2016 Feb;31(1):81-91
pubmed: 26616173
Obstet Gynecol. 2015 Jun;125(6):1529-1537
pubmed: 26000541
JAMA. 1991 Apr 17;265(15):1961-7
pubmed: 2008025
Addiction. 2019 Sep;114(9):1659-1669
pubmed: 31111591

Auteurs

Steven J Ondersma (SJ)

Division of Public Health and Department of Obstetrics, Gynecology, and Reproductive Biology, Michigan State University, Flint, Michigan, USA onders12@msu.edu.

Lisa Todd (L)

Family Medicine and Public Health Sciences, Wayne State University School of Medicine, Detroit, Michigan, USA.

Samantha Jablonski (S)

Health Care Value-Business Analytics Division, Blue Cross Blue Shield of Michigan, Detroit, Michigan, USA.

Chaarushi Ahuja (C)

Department of Obstetrics, Gynecology, and Reproductive Science, Yale-New Haven Hospital, New Haven, Connecticut, USA.

Kathryn Gilstad-Hayden (K)

Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.

Gregory Goyert (G)

Division of Maternal Fetal Medicine, Henry Ford Health, Detroit, Michigan, USA.

Amy Loree (A)

Center for Health Policy & Health Services Research, Henry Ford Health System, Detroit, Michigan, USA.

Jaimee Heffner (J)

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Kimberly A Yonkers (KA)

Departments of Psychiatry and Obstetrics & Gynecology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH